// App-Quantinova.ai

FRI0290 : IDENTIFICATION OF AT RISK PATIENTS FOR CARDIAC MRI DETERMINED SUB-CLINICAL SSC-CARDIOMYOPATHY (CM)

Researchers

Presenter

  • L.A. Bissell

Principal Investigators

  • B. Erhayiem

  • E. Hensor

  • G. Fent

  • J.P. Greenwood

  • S. Plein

  • J. Andrews

  • M.H. Buch

Medical Centers

  • University of Leeds, Leeds, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Central Nervous System (CNS)

Disease

  • Pulmonary arterial hypertension

  • Diastolic dysfunction

  • Heart muscle disease

  • Hypertension

  • Scleroderma

  • Diabetes

  • Myositis

  • Mental retardation, X-linked, syndromic, 15

Biomarkers

  • Carboxypeptidase B1

  • Body mass index

  • Albumin/creatinine

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • SIF3

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved